Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001197350-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-16 | MIRM | BJERKHOLT ERIC | CFO | S - Sale+OE | $91.98 | -7,287 | 49.8K | -13% | -$670.3K |
| D | 2026-03-17 | 2026-03-15 | MIRM | BJERKHOLT ERIC | CFO | M - OptEx | — | +13.3K | 57.1K | +30% | — |
| D | 2026-03-17 | 2026-03-15 | MIRM | BJERKHOLT ERIC | CFO | M - OptEx | $0.00 | -13.3K | 6,666 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | S | D | 7,287 | $91.98 | 49,788 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 13,334 | — | 57,075 | D | — | — | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Derivative | Performance Restricted Stock Units | 2026-03-15 | M | D | 13,334 | $0.00 | 6,666 | D | — · — to — | 13,334 Common Stock | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. |